Dabrafenib + Trametinib in cancer treatment
Dear Grampian Health Board,
I would be grateful if you could please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.
A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:
i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer
Many thanks for taking the time to answer these questions.
Yours faithfully,
Oliver Caswell
Dear Mr Caswell,
Freedom of Information (Scotland) Act 2002
Thank you for your email dated 31 March 2023, requesting information
regarding dabrafenib & trametinib in cancer treatment. We have recorded
this request and are currently processing it in accordance with the
Freedom of Information (Scotland) Act 2002.
A response to your request for information is due by 2 May 2023. Please
allow for delivery time.
We will contact you again in due course.
Best wishes,
Roohi
Roohi Bains
Information Governance Manager & Deputy DPO
Information Governance Team
NHS Grampian
Rosehill House
Cornhill Road
Aberdeen
AB25 2ZG
Phone: 01224 551319
[1][NHS Grampian request email]
--------------------------------------------------------------------------------------------------------------------------------------------------------
This email is intended for the named recipient only. If you have received
it by mistake,
please (i) contact the sender by email reply; (ii) delete the email from
your system; .
and (iii) do not copy the email or disclose its contents to anyone.
--------------------------------------------------------------------------------------------------------------------------------------------------------
References
Visible links
1. mailto:[NHS Grampian request email]
Dear Mr Caswell
Please find attached response to your request.
Regards
Chris
Chris Morrice
Senior Information Governance Officer
NHS Grampian
Rosehill House
ARI
AB25 2ZG
Email: [email address]
--------------------------------------------------------------------------------------------------------------------------------------------------------
This email is intended for the named recipient only. If you have received
it by mistake,
please (i) contact the sender by email reply; (ii) delete the email from
your system; .
and (iii) do not copy the email or disclose its contents to anyone.
--------------------------------------------------------------------------------------------------------------------------------------------------------
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now